Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in development

14 Jun 2019

Abstract excerpt

Introduction: Neuroinflammation is a common pathophysiological mechanism in neurodegenerative diseases (ND). Cerebrospinal fluid (CSF) YKL-40 has recently been candidated as a neuroinflammatory biomarker of ND.Areas covered: We provide an update on the role of CSF YKL-40 as a pathophysiological biomarker of ND. YKL-40 may discriminate Alzheimer’s disease (AD) from controls and may predict the progression from the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Amyotrophic Lateral Sclerosis Research
Share to Prion Diseases and Protein Misfolding

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31195846
DOI: 10.1080/14789450.2019.1628643

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in developmentPMID 31195846Read ↗

YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer’s DiseaseSemantic proximity Read ↗

CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementiaSemantic proximity Read ↗

Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's diseaseSemantic proximity Read ↗

Cerebrospinal Fluid YKL-40 and Neurogranin in Familial Alzheimer's Disease: A Pilot Study.Semantic proximity Read ↗

Synaptic, axonal damage and inflammatory cerebrospinal fluid biomarkers in neurodegenerative dementias.Semantic proximity Read ↗

Alterations in Lysosomal, Glial and Neurodegenerative Biomarkers in Patients with Sporadic and Genetic Forms of Frontotemporal DementiaSemantic proximity Read ↗

Deciphering the mechanism underlying late-onset Alzheimer diseaseSemantic proximity Read ↗

Neurochemical biomarkers in the diagnosis of frontotemporal lobar degeneration: an updateSemantic proximity Read ↗

Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosisSemantic proximity Read ↗

Cerebrospinal Fluid Chitinases as Biomarkers for Amyotrophic Lateral SclerosisSemantic proximity Read ↗

In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseasesSemantic proximity Read ↗

CSF neurogranin levels as a biomarker in Alzheimer’s disease and frontotemporal lobar degeneration: a cross-sectional analysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.